Occult Hepatitis B Virus Infection in Chronic Hemodialysis Patients in Korea

被引:0
作者
Gwak, Geum-Youn [1 ]
Huh, Wooseong [1 ]
Lee, Dong Ho [1 ]
Min, Byung-Hoon [1 ]
Koh, Kwang Cheol [1 ]
Kim, Jae J. [1 ]
Oh, Ha-Young [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea
关键词
Occult hepatitis B virus infection; Hemodialysis; Korea;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Occult HBV infection that is serum HBsAg negative but HBV-DNA positive is thought to be a contributing factor to ongoing HBV transmission within hemodialysis units. In the present study, the prevalence of occult HBV infection was investigated in patients on chronic hemodialysis in Korea, an endemic region for HBV. Methodology: Eighty-three patients undergoing maintenance hemodialysis at Samsung Medical Center, Seoul, South Korea were included. Serum samples were obtained from all patients. Testing for HBsAg, anti-HBs and anti-HBc was performed by an electrochemiluminescence immunoassay. HBV DNA was detected by the nested PCR method. Results: Among the 83 patients, 4 (4.8%) were HBsAg positive and HBV DNA positive. The remaining 79 patients were confirmed HBsAg-negative/HBV DNA-negative. Thus, the prevalence of occult HBV infection was 0%. All of the HBsAg-positive patients were anti-HBs-negative/anti-HBc-positive. Of 79 HBsAg-negative patients, 58 (73.4%) were anti-HBs positive and 52 (65.8%) were anti-HBc positive. Conclusions: The present study showed that the prevalence of occult HBV infection in chronic hemodialysis patients at our center in Korea was not increased compared to the rates of low endemic regions. Furthermore, occult HBV infection was not a contributing factor in HBV transmission in the hemodialysis unit studied.
引用
收藏
页码:1721 / 1724
页数:4
相关论文
共 15 条
  • [1] Cabrerizo M, 1997, J AM SOC NEPHROL, V8, P1443
  • [2] Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases
    Cabrerizo, M
    Bartolomé, J
    Caramelo, C
    Barril, G
    Carreño, V
    [J]. HEPATOLOGY, 2000, 32 (01) : 116 - 123
  • [3] Centers for Disease Control, 1988, MMWR Morb Mortal Wkly Rep, V37, P377
  • [4] DUEYMES JM, 1993, KIDNEY INT, V43, pS161
  • [5] Occult hepatitis B virus infection in dialysis patients: a multicentre survey
    Fabrizi, F
    Messa, PG
    Lunghi, G
    Aucella, F
    Bisegna, S
    Mangano, S
    Villa, M
    Barbisoni, F
    Rusconi, E
    Martin, P
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (11) : 1341 - 1347
  • [6] Serological and molecular testing in hepatitis B and the dialysis patient
    Fabrizi, F
    Lunghi, G
    Martin, P
    Poordad, FF
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (02) : 91 - 99
  • [7] HEPATITIS-B VIRUS MARKERS IN 97 LONG-TERM HEMODIALYSIS-PATIENTS
    GAHL, GM
    HESS, G
    ARNOLD, W
    GRAMS, G
    [J]. NEPHRON, 1979, 24 (02) : 58 - 63
  • [8] Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers
    Hou, JL
    Wang, ZH
    Cheng, JJ
    Lin, YL
    Lau, GKK
    Sun, J
    Zhou, FY
    Waters, J
    Karayiannis, P
    Luo, KX
    [J]. HEPATOLOGY, 2001, 34 (05) : 1027 - 1034
  • [9] Jang Myoung Kuk, 2001, Korean Journal of Internal Medicine, V16, P153
  • [10] Perspective: Chronic hepatitis B
    Lok, ASF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) : 1682 - 1683